The Difference between Traditional and AI Algorithms in Medtech: A Biostatistician’s Perspective
Software as a Medical Device now constitutes a substantial share of new medical device approvals, and the algorithms within these products span the full range from classical regression to deep learning. In the UK, software qualifying as a medical device falls under the Medical Devices Regulations 2002 as amended, with the MHRA providing specific guidance on software and artificial intelligence as a medical device. In the EU, standalone software…
Diagnostic, Prognostic, and Disease Monitoring Algorithms: What They Are and How Their Statistical Validation Differs
AI Algorithms now sit at every point in the patient pathway. They identify who has a disease, forecast what will happen next, and track change over time. The statistical machinery needed to validate each of these three types is fundamentally different. A model that classifies a patient as "disease-positive" at a single timepoint is not validated the same way as one that predicts 5-year survival. Neither maps neatly onto…
CRF Design for Clinical Studies: The Distinct Roles of Data Managers vs Biostatisticians
In clinical trials, the Case Report Form (CRF) is more than a tool for collecting data, it’s the backbone of the study. From capturing critical safety outcomes to evaluating device performance, a well-designed CRF ensures that the study’s goals are met efficiently and reliably. Achieving this balance requires input from two key roles: the data manager and the biostatistician. While their contributions may overlap in some areas, these roles…
Strategic Biometrics: The Case for Outsourcing in Medical Device Clinical Investigations
The integrity of a clinical investigation relies entirely on the precision of its data. As trial designs grow more complex, the scope of biometrics expands accordingly. Biometrics spans biostatistics, statistical programming, and data management. Medtech sponsors often build internal data teams, sometimes assuming that general data science or AI expertise translates to sound regulatory biostatistics. Clinical investigations, however, require a highly specific regulatory and statistical framework. Building a dedicated…
Fake vs Synthetic Data: What’s the difference?
The ethical and accurate handling of data is paramount in the domain of clinical research. As the demand for data-driven clinical insights continues to grow, researchers face challenges in balancing the need for accuracy with the availability of data and the imperative to protect sensitive information. In situations where not enough quality real patient data is available, synthetic data can be the most reliable data source from which to…
The Role of Clinical-Translational Studies in Validation of Diagnostic Devices
Clinical-translational studies represent the critical inflection point where a diagnostic technology transitions from a laboratory assay to a validated clinical asset. Understanding the distinction between translational research and formal clinical investigations, and how they sequence together, is essential for designing an efficient regulatory and statistical strategy. Navigating the Diagnostic Device Landscape Before examining the translational phase, it is vital to distinguish between the two primary categories of diagnostic devices,…
Checklist for proactive regulatory compliance in medical device R&D projects
In the highly regulated medical device sector, compliance cannot be retrofitted onto a finished product. A proactive, "compliance-by-design" approach that integrates regulatory and biostatistical considerations from concept through post-market is essential for market approval and patient safety. Below is a concise framework for embedding regulatory rigour into your R&D and clinical trial processes. Phase 1: R&D and Quality Framework Regulatory Strategy & Gap Analysis: Engage regulatory experts at concept…
Balancing Innovation and Safety: Navigating Global Medical Device Regulation
In the fast-paced world of medical technology, the drive for rapid innovation must be carefully balanced with patient safety. While pushing the boundaries of engineering is essential for advancing healthcare, it must never come at the expense of rigorous safety standards. When regulatory oversight fails to keep pace with technological advancement, or when loopholes allow for lower standards in certain markets, patient safety can be compromised. Fortunately, the medical…
Stata: Statistical Software for Regulatory Compliance in Clinical Trials
Stata has been widely used for decades in various research domains such as economics, biosciences, health and social sciences, including clinical trials. It is widely referenced in studies published in reputable scientific journals. While SAS has a longer history of being explicitly referenced by regulatory agencies such as the FDA, Stata can still meet regulatory compliance requirements in clinical trials. StataCorp actively engages with researchers, regulatory agencies, and industry…